Dronedarone in patients with congestive heart failure: insights from ATHENA

Stefan H Hohnloser; Harry J G M Crijns; Martin van Eickels; Christophe Gaudin; Richard L Page; Christian Torp-Pedersen; Stuart J Connolly; ATHENA Investigators

doi:10.1093/eurheartj/ehq113

Dronedarone in patients with congestive heart failure: insights from ATHENA

Stefan H Hohnloser, Harry J G M Crijns, Martin van Eickels, Christophe Gaudin, Richard L Page, Christian Torp-Pedersen, Stuart J Connolly, ATHENA Investigators

63 Citationer (Scopus)

Abstract

Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.

Originalsprog	Engelsk
Tidsskrift	European Heart Journal
Vol/bind	31
Udgave nummer	14
Sider (fra-til)	1717-21
Antal sider	5
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehq113
Status	Udgivet - 1 jul. 2010

Adgang til dokumentet

10.1093/eurheartj/ehq113

Citationsformater

@article{be1b1b448fe34bde9cb5ee0623ba52c2,

title = "Dronedarone in patients with congestive heart failure: insights from ATHENA",

abstract = "Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.",

author = "Hohnloser, {Stefan H} and Crijns, {Harry J G M} and {van Eickels}, Martin and Christophe Gaudin and Page, {Richard L} and Christian Torp-Pedersen and Connolly, {Stuart J} and {ATHENA Investigators}",

year = "2010",

month = jul,

day = "1",

doi = "10.1093/eurheartj/ehq113",

language = "English",

volume = "31",

pages = "1717--21",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "14",

}

TY - JOUR

T1 - Dronedarone in patients with congestive heart failure: insights from ATHENA

AU - Hohnloser, Stefan H

AU - Crijns, Harry J G M

AU - van Eickels, Martin

AU - Gaudin, Christophe

AU - Page, Richard L

AU - Torp-Pedersen, Christian

AU - Connolly, Stuart J

AU - ATHENA Investigators

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.

AB - Dronedarone is a new multichannel blocking antiarrhythmic drug for treatment of atrial fibrillation (AF). In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. The present study aimed to analyse in detail the effects of dronedarone on mortality and morbidity in AF patients CHF.

U2 - 10.1093/eurheartj/ehq113

DO - 10.1093/eurheartj/ehq113

M3 - Journal article

C2 - 20436046

SN - 0195-668X

VL - 31

SP - 1717

EP - 1721

JO - European Heart Journal

JF - European Heart Journal

IS - 14

ER -

Dronedarone in patients with congestive heart failure: insights from ATHENA

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater